Literature DB >> 32581466

Anterior Chamber Angle, Intraocular Pressure, and Globe Biometric Parameters in the Children with β-Thalassemia Major.

Nermien Sm El-Haddad1.   

Abstract

BACKGROUND: To evaluate the intraocular pressure (IOP), anterior chamber angle (ACA), and globe biometric parameters in β-thalassemia major children and the correlations of these changes.
MATERIALS AND METHODS: Eighty-four eyes were included (42 eyes of thalassemia patients and 42 eyes of control). All participates underwent head circumference and height measurements, full ophthalmic examination, anterior segment optical coherence tomography (AS-OCT), and A-scan biometry.
RESULTS: The temporal angle of anterior chamber (T-ACA) was significantly narrower in thalassemia patients with p value = 0.008. While the nasal angle showed a nonsignificant narrowing with p value = 0.153. This narrowing was positively correlated with the height, and negatively correlated with the head circumference. Intraocular pressure was statistically higher in thalassemia patients with p value = 0.000. The increased IOP was positively correlated with the head circumference and the lens thickness (LT) and negatively correlated with T-ACA, axial length (AL), vitreous chamber depth (VCD), and anterior chamber depth (ACD). Axial length, ACD, and VCD significantly decreased with p value = 0.000 for all with a positive correlation with the height and a negative correlation with the head circumference. The LT increased in thalassemia group with p value = 0.000. This increase was positively correlated with the head circumference and negatively with the height. Also, there was steeper corneal curvature in thalassemia group with p value = 0.023 and 0.015 (for K1 and K2, respectively). No significant change was observed in corneal thickness in both groups with p value = 0.810.
CONCLUSION: Narrower T-ACA, increased IOP, shorter (AL, VCD, and ACD), steeper corneal curvature, and thicker lens were found in thalassemia patients. HOW TO CITE THIS ARTICLE: El-Haddad NSM. Anterior Chamber Angle, Intraocular Pressure, and Globe Biometric Parameters in the Children with β-Thalassemia Major. J Curr Glaucoma Pract 2020;14(1):30-36.
Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.

Entities:  

Keywords:  Anterior chamber angle; Corneal curvature; Effective lens position; Globe biometric parameters and intraocular pressure; β-Thalassemia

Year:  2020        PMID: 32581466      PMCID: PMC7302607          DOI: 10.5005/jp-journals-10078-1274

Source DB:  PubMed          Journal:  J Curr Glaucoma Pract        ISSN: 0974-0333


INTRODUCTION

One of the most common inherited blood disorders is thalassemia major. It is caused by mutation in the gene responsible for the synthesis of the beta chain of adult hemoglobin. Red blood cell maturation leads to ineffective erythropoiesis.[1] Chronic anemia, iron accumulation in the tissues resulting from the red blood cell destruction, repeated blood transfusion, and the use of iron chelators (all these factors) affect organs negatively.[2] β-Thalassemia affects more than 42,000 newborns every year all over the world. Populations with the highest prevalence are the Mediterranean, Central Asia, Middle East, India, and the Far East.[3] β-Thalassemia major has both systemic and ocular affections. β-Thalassemia affects both anterior and posterior segments of the eye. Ocular surface disorder with goblet cell loss and squamous metaplasia of the conjunctiva,[4] abnormal conjunctival vessels, against-the-rule pattern astigmatism, steeper corneal curvature, cataract, and thicker lens are some of the anterior segment manifestations of β-thalassemia major. However, retinal pigment epithelium (RPE) degeneration, RPE hypertrophy, angioid streaks, venous tortuosity, and optic nerve head drusen are some posterior segment manifestations. Other manifestations include shorter axial length (AL),[2] color blindness, and decrease in the visual acuity. The aim of this study was to find the effect of β-thalassemia on the angle of anterior chamber (ACA), intraocular pressure (IOP), and the other globe parameters.

MATERIALS AND METHODS

The study included 84 eyes. Forty-two eyes of children with thalassemia major (18 male and 24 female) and 42 eyes of control healthy children of the same age-group (12 male and 30 female). The thalassemia major children are on blood transfusion iron-chelating agents. Informed consent was obtained from the parents after detailed information was given. The study protocol was approved by the declaration of Helsinki protocol. Exclusion criteria included amblyopia, aphakia, strabismus, cataract surgery, history of corneal disease, and systemic disease effect on refractive errors. Head circumference, height, and weight were recorded for all patients. Complete ophthalmologic examinations were performed for all participants, including the best corrected visual acuity (BCVA), slit lamp biomicroscopic examination, external eye examination, IOP by Goldmann applanation tonometery and fundoscopy.

Refraction

Cycloplegic refraction (using 0.5% cyclopentolate hydrochloride) and the corneal astigmatism were determined using an auto kerato-refractometer. The final result was taken as the average of three consecutive readings.

Anterior Segment Optical Coherence Topography

NIDEK RS-3000 retinal scan with anterior segment module was used for anterior segment optical coherence topography (AS-OCT) measurements. Patients, with undilated pupils, fixated to AS-OCT. The ACA line was used to image the nasal and temporal angle quadrants (180° and 0° meridians). Both the quality and centration of image should be sufficient for analysis. The central corneal thickness (CCT) was measured using the cornea radial scan pattern. The best images were selected for being analyzed to measure the CCT and ACA. The ACA width was calculated by measuring the angle between the iris tangential line and the posterior corneal surface with its apex in the angle recess.

A-scan Ultrasonography

A-scan ultrasonography was used for measurement of ocular components anterior chamber depth (ACD), lens thickness (LT), AL, and vitreous chamber depth (VCD). The monitor A&B scan biometer was used following corneal anesthesia with tetracaine HCL. The patients were requested to lay in a supine position and look at a far object to neutralize the accommodation effect on the measured LT. The fingers were used to hold the lids apart. Excessive pressure on the globe should be avoided. The measures were obtained by applying the probe tip to touch the cornea. Five measurements per eye were taken. Relative lens position is the relative position of the center of the lens which is calculated by adding half the LT to the ACD and then dividing the sum by the AL multiplied by 10 [ACD + 0.5 × LT/AL × 10]. The data were collected and then statistically analyzed by using Mann–Whitney test, independent t test, Chi-square test, and Spearman test.

RESULTS

In this study, the mean age of thalassemia patients was 16.43 ± 3.99, and for the control group was16.29 ± 3.83. The height of thalassemia patients was significantly shorter than the control group with p value of 0.000. However, the head circumference in thalassemia group was more than the control group with p value of 0.000 (Table 1). An insignificant change was observed in best corrected visual acuity (BCVA) with p value of 0.306 (Table 2).
Table 1

Demographic and general characteristics of participants

Control groupPatient groupTest valuep valueSig.
No. = 42No. = 42
SexMale12 (71.4%)18 (57.1%)  0.6220.430NS
Female30 (28.6%)24 (42.9%)
AgeMean ± SD16.29 ± 3.8316.43 ± 3.99−0.0970.924NS
Range10–219–21
HeightMean ± SD153.71 ± 3.67148.57 ± 2.65  4.2520.000HS
Range149–159143–151
Head circumferenceMean ± SD53.93 ± 0.7655.67 ± 0.77−6.0510.000HS
Range53–5554.5–57
Table 2

Anterior chamber angles, corneal astigmatism, corneal thickness, intraocular pressure, and visual acuity in thalassemia patients and control group

Control groupPatient groupTest valuep valueSig.
No. = 42No. = 42
T-ACAMean ± SD35.64 ± 2.3033.23 ± 2.09  2.8960.008HS
Range29.9–38.229.5–35.9
N-ACAMean ± SD33.28 ± 3.4731.64 ± 2.29  1.4730.153NS
Range23.9–36.726.8–35.6
C.astigMedian (IQR)−0.75 (−1 to −0.5)−0.75 (−1.25 to −0.75)  0.6010.635NS
Range−2.25 to −0.25−1.75 to −0.25
AxisMedian (IQR)34.00 (13–113)91.00 (76–100)  0.1480.150NS
Range4–18247–176
IOPMean ± SD12.07 ± 1.3315.21 ± 1.12−6.7650.000HS
Range10–1413–17
Corneal thicknessMean ± SD511.86 ± 8.75510.64 ± 16.57  0.2420.810NS
Range495–525487–545
BCVAMedian (IQR)0.00 (0–0)0.00 (0–0.2)  0.2050.306NS
Range0–0.20–0.3

T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle; C.astig, corneal astigmatism; IOP, intraocular pressure; BC VA, best corrected visual acuity

As regards the ACA, the temporal angle (T-ACA) in thalassemia patients was significantly narrower than the control group with p value of 0.008. While the nasal angle showed a nonsignificant narrowing with p value of 0.153 (Table 2), the angle of anterior chamber was positively correlated with height and negatively correlated with the head circumference and IOP. The IOP was statistically higher in thalassemia patients with p value of 0.000 (Table 2). The increased IOP was positively correlated with the head circumference and the LT. However, it was negatively correlated with T-ACA, AL, VCD, and ACD (Figs 1 to 5).
Fig. 1

A negative correlation between intraocular pressure and axial length

Fig. 5

A negative correlation between intraocular pressure and temporal anterior chamber angle

Demographic and general characteristics of participants Anterior chamber angles, corneal astigmatism, corneal thickness, intraocular pressure, and visual acuity in thalassemia patients and control group T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle; C.astig, corneal astigmatism; IOP, intraocular pressure; BC VA, best corrected visual acuity AL, ACD and VCD were significantly shorter in in thalassemia group than the control group with p value = 0.000 for all (Table 3); AL, ACD, and VCD were positively correlated with the height and negatively correlated with the head circumference and IOP (Figs 6 to 17).
Table 3

Biometric parameters for the control and thalassemia groups

Control groupPatient groupTest valuep valueSig.
No. = 42No. = 42
ALMean ± SD23.87 ± 0.4122.56 ± 0.74  5.7420.000HS
Range22.9–24.4221.42–23.75
ACDMean ± SD3.54 ± 0.172.89 ± 0.33  6.5790.000HS
Range3.28–3.832.46–3.46
Lens thicknessMean ± SD3.56 ± 0.143.96 ± 0.19−6.3100.000HS
Range3.24–3.783.66–4.25
Vitreous chamber depthMean ± SD16.03 ± 0.2415.10 ± 0.2110.9600.000HS
Range15.75–16.4314.83–15.45
Relative lens positionMean ± SD2.22 ± 0.082.16 ± 0.10  1.7630.090NS
Range2.05–2.342.01–2.32
K1Mean ± SD41.59 ± 1.5242.88 ± 1.28−2.4190.023S
Range37.5–4341.75–45.5
K2Mean ± SD42.44 ± 1.3743.86 ± 1.50−2.6080.015S
Range39.65–4442.25–47

AL, axial length; ACD, anterior chamber depth; K1, the flatter corneal curvature; K2, the steeper corneal curvature

Fig. 6

A positive correlation between height and axial length

Fig. 17

A negative correlation between the head circumference and temporal anterior chamber angle

The lens was thicker in the thalassemia group than the control group with p value of 0.000 (Table 3). This increase in LT was positively correlated with the head circumference and IOP but negatively correlated with the height (Table 4). As regards relative lens position, no difference was found between both groups with p value of 0.090 (Table 3).
Table 4

Correlation of the parameters with height, head circumference, and intraocular pressure (IOP)

HeightH. CircumIOP
rp valuerp valuerp value
Height−0.535  0.003−0.463  0.013
Head circumference−0.535  0.003−0.535  0.003
IOP−0.463  0.013  0.501  0.007
AL  0.445  0.018−0.501  0.007−0.765  0.000
ACD  0.641  0.000−0.663  0.000−0.676  0.000
Lens thickness−0.484  0.009  0.609  0.001  0.657  0.000
Vitreous chamber depth  0.477  0.010−0.599  0.001−0.725  0.000
T-ACA  0.407  0.032−0.471  0.011−0.427  0.024
N-ACA  0.464  0.013−0.349  0.069−0.338  0.078

AL, axial length; ACD, anterior chamber depth; IOP, intraocular pressure; T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle

A negative correlation between intraocular pressure and axial length A negative correlation between intraocular pressure and anterior chamber depth A positive correlation between intraocular pressure and lens thickness A negative correlation between intraocular pressure and vitreous chamber depth A negative correlation between intraocular pressure and temporal anterior chamber angle Biometric parameters for the control and thalassemia groups AL, axial length; ACD, anterior chamber depth; K1, the flatter corneal curvature; K2, the steeper corneal curvature A positive correlation between height and axial length A positive correlation between height and anterior chamber depth A negative correlation between height and lens thickness A positive correlation between height and vitreous chamber depth A positive correlation between height and temporal anterior chamber angle A positive correlation between height and nasal anterior chamber angle A positive correlation between the head circumference and intraocular pressure A negative correlation between the head circumference and axial length A negative correlation between the head circumference and anterior chamber depth A positive correlation between the head circumference and lens thickness A negative correlation between the head circumference and vitreous chamber depth A negative correlation between the head circumference and temporal anterior chamber angle Correlation of the parameters with height, head circumference, and intraocular pressure (IOP) AL, axial length; ACD, anterior chamber depth; IOP, intraocular pressure; T-ACA, temporal anterior chamber angle; N-ACA, nasal anterior chamber angle Also, there was steeper corneal curvature in thalassemia group with p value of 0.023 and 0.015 (for K1 and K2, respectively). No significant change was observed in corneal thickness in both groups with p value of 0.810 (Table 3).

DISCUSSION

Thalassemia major is a hereditary disease that affects those living in the Mediterranean area, including Egypt, especially with a high incidence of the consanguineous marriages. The disease needs long-lasting follow-up and treatment. It creates an economic and social problem. Many factors affect the life span and the systemic symptoms such as the patient's socioeconomic and environmental situation. The progression of the disease in patients with thalassemia major, frequent blood transfusions, and the usage of chelating agents could affect the systemic symptoms.[5] So, it is important to study the effect of thalassemia in different countries. In this study, ACA was reported to be narrower in thalassemia patients, T-ACA was statistically significant, but N-ACA was statistically nonsignificant. There were no references to other studies to compare these results with others. This narrowing in T-ACA may be due to the increased length thickness that bush iris anteriorly, leading to T-ACA narrowing in the same mechanism of narrowing the angle with age. The affection of temporal angle with sparing of nasal angle is not well understood. But this finding has been found by Chen et al.[6] who reported that the temporal angle is the angle that narrows with age. The corneal thickness in both groups was not statistically different. So the increased IOP in thalassemia patients reported in this study and in other studies was not due to the difference in pachymetery. But it may be due to steeper corneal curvature as explained by Nowroozzadeh et al.[7] However, the increased IOP in thalassemia patients may be due to the short AL, ACD, and VCD and due to the thick lens as supported by the negative correlation between the IOP and AL, ACD, and VCD found in this study (Figs 1 and 2). Also, the positive correlation between the LT and IOP reinforces this hypothesis. The narrower T-ACA may play a role in the increased IOP because a negative correlation between IOP and T-ACA was found in this study (Fig. 5).
Fig. 2

A negative correlation between intraocular pressure and anterior chamber depth

Thalassemia major affects the biometric parameters of the globe. In this study, the AL, ACD, and VCD decreased in thalassemia patients. This matches with Khalaj et al.,[8] Nowroozzadeh et al.,[7] Heydarian et al.,[9] and Elkitkat et al.[10] All reported shorter AL and ACD of thalassemia patients. This can be due to the skeletal abnormality affecting the bony orbit as a result of the bone marrow expansion. Pereira and Allemann[11] found a correlation between AL, ACD, VCD and the height in normal population. As thalassemia patients have shorter height, they have shorter AL, ACD, and VCD as a part of generalized growth retardation. This hypothesis was supported by the positive correlation between the AL, ACD, VCD, and the height found in my study (Figs 6 to 9).
Fig. 9

A positive correlation between height and vitreous chamber depth

This study demonstrated an increase in LT in thalassemia patients as reported in some studies.[7-10] The cause of this is not well understood. It might be due to precipitation of iron in lens matter. Despite the lens was thicker in thalassemia patients compared to the control, the relative lens position did not show statistical difference in both groups. This is because the increased LT is compensated by the short AL and ACD. The thalassemia patients had steeper corneal curvature than the control group, which has been reported by Nowroozzadeh et al.,[7] Heydarian et al.,[9] and Elkitkat et al.[10] The cause of this steep cornea has not been understood yet, but the change in a bony orbit may be the cause or it may be a compensatory mechanism for short AL. The steeper corneal curvature and the increased LT compensate shorter AL. So no statistical difference in BCVA.

CONCLUSION

Thalassemia affects ACA, IOP, and the biometric globe parameters. Narrower T-ACA and increased IOP were found in thalassemia patients. Shorter AL, VCD, and ACD were reported. Also, steeper corneal curvature and thicker lens were found. The CCT and the relative lens position were the same in both thalassemia patients and control groups.
  10 in total

1.  [Ocular biometry, refractive error and correlation with height, age, gender and years of formal education].

Authors:  Graziela Campanelli Pereira; Norma Allemann
Journal:  Arq Bras Oftalmol       Date:  2007 May-Jun       Impact factor: 0.872

2.  Anterior chamber angle biometry: quadrant variation, age change and sex difference.

Authors:  H B Chen; K Kashiwagi; S Yamabayashi; T Kinoshita; B Ou; S Tsukahara
Journal:  Curr Eye Res       Date:  1998-02       Impact factor: 2.424

3.  Ocular findings in children with thalassemia major in Eastern Mediterranean.

Authors:  Adnan Aksoy; Murat Aslankurt; Lokman Aslan; Ozlem Gül; Mesut Garipardıç; Oğuz Celik; Seydi Okumuş; Murat Ozdemir; Gökhan Ozdemir
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

4.  Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia.

Authors:  Rania S Elkitkat; Amany A El-Shazly; Weam M Ebeid; Marwa R Deghedy
Journal:  Eur J Ophthalmol       Date:  2018-03       Impact factor: 2.597

5.  Ocular refractive and biometric characteristics in patients with thalassaemia major.

Authors:  Mohammad Hosein Nowroozzadeh; Zahra Kalantari; Khadije Namvar; Mohammad Hassan Meshkibaf
Journal:  Clin Exp Optom       Date:  2011-02-16       Impact factor: 2.742

6.  Multiple transfused thalassemia major: ocular manifestations in a hospital-based population.

Authors:  Rashi Taneja; Pankaj Malik; Mamta Sharma; Mahesh C Agarwal
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

7.  Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience.

Authors:  Jitendra Jethani; Kenshuk Marwah; Shashank Patel; Bela Shah
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

8.  Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia.

Authors:  S P Gartaganis; C D Georgakopoulos; A Exarchou; E K Mela; C Psachoulia; M I Eliopoulou; A Kourakli; S S Gotsis; R C Tripathi
Journal:  Cornea       Date:  2003-10       Impact factor: 2.651

9.  Refractive errors and ocular biometry components in thalassemia major patients.

Authors:  Samira Heydarian; Reza Jafari; Hosein Karami
Journal:  Int Ophthalmol       Date:  2015-12-08       Impact factor: 2.031

Review 10.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.